Founding members

101 has been brought to life by 6 physician-scientists with an international reputation in intensive care medicine. They share a broad experience in clinical and basic research, organisation and evaluation of care, as well as education and scientific communication. They have initiated and participated in major quality-improvement international campaigns, and have identified barriers to the development of precision medicine in intensive care.

Pr. Jean-Daniel CHICHEPU-PH - Dept of Intensive Care Medecine, Chairman at CHUV, Lausanne

Pr. Jean-Daniel CHICHE

PU-PH - Dept of Intensive Care Medecine, Chairman at CHUV, Lausanne

Pr. Derek ANGUSPU-PH - Critical Care Medicine at UPMC ICU Service Center and University of Pittsburgh School of Medicine - Director of the CRISMA research group

Pr. Derek ANGUS

PU-PH - Critical Care Medicine at UPMC ICU Service Center and University of Pittsburgh School of Medicine - Director of the CRISMA research group

Pr. Djillali ANNANEPU-PH - Intensive Care Medicine at Raymond Poincaré Hospital (AP-HP), Paris Saclay - Dean of the Faculty of Health Sciences at the Versailles University

Pr. Djillali ANNANE

PU-PH - Intensive Care Medicine at Raymond Poincaré Hospital (AP-HP), Paris Saclay - Dean of the Faculty of Health Sciences at the Versailles University

Pr. Elie AZOULAYPU-PH - Intensive Care Medecine at Saint-Louis Hospital (AP-HP) and Paris Diderot Universit - Director of the Famirea Research Group

Pr. Elie AZOULAY

PU-PH - Intensive Care Medecine at Saint-Louis Hospital (AP-HP) and Paris Diderot Universit - Director of the Famirea Research Group

Dr. Isabelle BIKARTMedical Affairs Lead - France at Organon  & Co.

Dr. Isabelle BIKART

Medical Affairs Lead - France at Organon & Co.

Pr. Andrew RHODESPU-PH - Anaesthesia and Intensive Care Medicine at St George’s University Hospitals NHS Foundation Trust, London - Consultant at St George’s Hospital, Londres

Pr. Andrew RHODES

PU-PH - Anaesthesia and Intensive Care Medicine at St George’s University Hospitals NHS Foundation Trust, London - Consultant at St George’s Hospital, Londres

Board of directors

101’s Board of Directors brings together personalities from civilian society with various professional backgrounds. The board sets the strategic orientations and the different modes of operation and guarantees shared governance. 

Pr. Jean-Daniel CHICHE101 PresidentPU-PH - Dept of Intensive Care Medecine, Chairman at CHUV, LausanneLinkedIn

Pr. Jean-Daniel CHICHE

101 President

PU-PH - Dept of Intensive Care Medecine, Chairman at CHUV, Lausanne

LinkedIn

Nicolas HARLÉPresident of the BoardManaging Director of Nova ConsultingLinkedIn

Nicolas HARLÉ

President of the Board

Partner at Bain & Company

LinkedIn

Olivier ABERGELChairman of the Campaign CommitteeLawyer, Managing Partner at LL BERGLinkedIn

Olivier ABERGEL

Chairman of the Campaign Committee

Lawyer, Managing Partner at LL BERG

LinkedIn

Roxane ROUASTreasurerExecutive Director of Freemantle

Roxane ROUAS

Treasurer

Executive Director of Freemantle


Dr. Isabelle BIKARTSecretaryMedical Affairs Lead - France at Organon  & Co.LinkedIn

Dr. Isabelle BIKART

Secretary

Medical Affairs Lead - France at Organon & Co.

LinkedIn

Patrice FONLLADOSAPresident of the Investment Advisory CommitteeChairman of (Re)sources LinkedIn

Patrice FONLLADOSA

President of the Investment Advisory Committee

Chairman of (Re)sources

LinkedIn

Pr. Djillali ANNANEPU-PH - Intensive Care Medicine at Raymond Poincaré Hospital (AP-HP), Paris Saclay - Dean of the Faculty of Health Sciences at the Versailles University

Pr. Djillali ANNANE

PU-PH - Intensive Care Medicine at Raymond Poincaré Hospital (AP-HP), Paris Saclay - Dean of the Faculty of Health Sciences at the Versailles University

Raphaël DE ANDRÉISCEO of Havas Village France

Raphaël DE ANDRÉIS

CEO of Havas Village France


Barbara BELVISICEO of Interstellar Labs

Barbara BELVISI

CEO of Interstellar Labs

Johanna BENESTYPartner and Managing Director at BCG (Paris)

Johanna BENESTY

Partner and Managing Director at BCG (Paris)

Guillaume BORIEDeputy CEO of AXA France

Guillaume BORIE

Deputy CEO of AXA France

Anne-Marie COUDERCNon-executive President of Air France - KLM

Anne-Marie COUDERC

Non-executive President of Air France - KLM


Céline LAZORTHESNon-executive Chairman of Leetchi

Céline LAZORTHES

Non-executive Chairman of Leetchi

Yann LECHELLECEO of Scaleway

Yann LECHELLE

CEO of Scaleway

Antoine MARTELInvestor

Antoine MARTEL

Investor

Sidney TOLEDANOCEO of LVMH Fashion Group

Sidney TOLEDANO

CEO of LVMH Fashion Group


Paul YOUNÈSPartner at Filib’

Paul YOUNÈS

Partner at Filib’

The scientific commitTee

The scientific committee is composed of 27 scientists of global renown. Clinicians, scientists, researchers, epidemiologists and educators that all have a strong background in all domains linked to intensive care and the challenges it faces.

This committee assists the executive board in the selection of projects and the grant applications. They also assist the founding members and the national coordinators of affiliated intensive care units in putting into place and developing 101’s research and education programs.

Operational team

7 people are working from our office in Paris as our operational team which is tasked with the day-to-day management of the fund and the launch of new projects.